Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

Wednesday’s Trading Day
41.71 -0.21 / -0.50%
As of Feb 10
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
41.83 +0.12 / +0.29%
 
Volume: 250.00

Today’s Trading

Previous close41.92
Today’s open42.26
Day’s range41.34 - 42.42
Volume306,651
Average volume (3 months)502,667
Market cap$7.1B
Dividend yield0.75%
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)+1.86%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.43%
Revenue growth (last year)+10.96%
P/E ratio0.3
Price/Sales4.04
Price/Book4.00

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-0.21-0.18%
MNKMallinckrodt Plc-0.52-0.83%
IDXXIDEXX Laboratories I...+1.17+1.71%
TAROTaro Pharmaceutical ...-3.92-2.89%
Data as of 02/10/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)$0.59
Annual revenue (last year)$2.4B
Annual profit (last year)$362.0M
Net profit margin14.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts

Partner Offers